Electromed, Inc. (ELMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 12.22M USD | Liabilities, Current |
| Cash and equivalents | 20.45M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 29.80M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.68M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $12.22M | $20.45M | (m) | $29.80M | $3.68M | (m) |
| 2026-03-31 | (m) | $10.23M | $16.98M | (m) | $28.25M | $3.29M | (m) |
| 2025-12-31 | (m) | $9.38M | $13.79M | (m) | $26.26M | $3.46M | (m) |
| 2025-09-30 | (m) | $8.76M | $14.11M | (m) | $24.76M | $3.77M | (m) |
| 2025-06-30 | (m) | $10.47M | $15.29M | (m) | $24.66M | $3.30M | (m) |
| 2025-03-31 | (m) | $8.51M | $15.24M | (m) | $23.44M | $2.97M | (m) |
| 2024-12-31 | (m) | $8.67M | $16.23M | (m) | $22.77M | $3.08M | (m) |
| 2024-09-30 | (m) | $7.42M | $13.86M | (m) | $22.37M | $3.43M | (m) |
| 2024-06-30 | (m) | $7.68M | $16.08M | (m) | $23.33M | $3.71M | (m) |
| 2024-03-31 | (m) | $6.33M | $11.71M | (m) | $23.91M | $4.18M | (m) |
| 2023-12-31 | (m) | $6.57M | $10.43M | (m) | $22.99M | $4.76M | (m) |
| 2023-09-30 | (m) | $5.78M | $7.02M | (m) | $23.45M | $4.48M | (m) |
| 2023-06-30 | (m) | $8.05M | $7.37M | (m) | $24.13M | $4.22M | (m) |
| 2023-03-31 | (m) | $6.42M | $6.78M | (m) | $22.34M | $3.45M | (m) |
| 2022-12-31 | (m) | $6.01M | $6.91M | (m) | $21.55M | $3.47M | (m) |
| 2022-09-30 | (m) | $5.95M | $6.00M | (m) | $20.96M | $3.67M | (m) |
| 2022-06-30 | (m) | $7.15M | $8.15M | (m) | $21.05M | $3.18M | (m) |
| 2022-03-31 | (m) | $4.97M | $9.84M | (m) | $19.61M | $2.09M | (m) |
| 2021-12-31 | (m) | $4.67M | (m) | (m) | $19.11M | $1.79M | (m) |
| 2021-09-30 | (m) | $4.81M | (m) | (m) | $18.36M | $2.02M | (m) |
| 2021-06-30 | (m) | $4.64M | $11.89M | (m) | $17.03M | $2.11M | (m) |
| 2021-03-31 | (m) | $4.24M | (m) | (m) | $16.24M | $2.26M | (m) |
| 2020-12-31 | (m) | $3.49M | (m) | (m) | $15.40M | $2.60M | (m) |
| 2020-09-30 | (m) | $3.53M | (m) | (m) | $13.62M | $3.07M | (m) |
| 2020-06-30 | (m) | $2.99M | (m) | (m) | $12.94M | $3.08M | (m) |
| 2020-03-31 | (m) | $3.62M | (m) | (m) | $13.29M | $2.65M | (m) |
| 2019-12-31 | (m) | $2.99M | (m) | (m) | $12.72M | $2.65M | (m) |
| 2019-09-30 | (m) | $3.28M | (m) | (m) | $12.72M | $2.75M | (m) |
| 2019-06-30 | (m) | $3.62M | (m) | (m) | $12.76M | $2.62M | (m) |
| 2019-03-31 | (m) | $3.24M | (m) | (m) | $12.28M | $2.71M | (m) |
| 2018-12-31 | (m) | $3.07M | (m) | (m) | $11.94M | $2.74M | (m) |
| 2018-09-30 | (m) | $4.48M | (m) | (m) | $11.55M | $2.84M | (m) |
| 2018-06-30 | (m) | $4.74M | (m) | (m) | $11.56M | $2.36M | (m) |
| 2018-03-31 | (m) | $3.75M | (m) | (m) | $10.08M | $2.21M | (m) |
| 2017-12-31 | (m) | $3.78M | (m) | (m) | $9.68M | $2.39M | (m) |
| 2017-09-30 | (m) | $2.74M | (m) | (m) | $9.64M | $2.45M | (m) |
| 2017-06-30 | (m) | $2.90M | (m) | (m) | $9.95M | $2.56M | (m) |
| 2017-03-31 | (m) | $2.77M | (m) | (m) | $8.93M | $2.59M | (m) |
| 2016-12-31 | (m) | $2.36M | (m) | (m) | $8.28M | $2.57M | (m) |
| 2016-09-30 | (m) | $1.91M | (m) | (m) | $8.04M | $2.61M | (m) |
| 2016-06-30 | (m) | $3.07M | (m) | (m) | $7.61M | $2.48M | (m) |
| 2016-03-31 | (m) | $2.89M | (m) | (m) | $7.31M | $2.33M | (m) |
| 2015-12-31 | (m) | $2.43M | (m) | (m) | $6.90M | $2.39M | (m) |
| 2015-09-30 | (m) | $2.13M | $3.78M | (m) | $6.46M | $2.16M | (m) |
| 2015-06-30 | (m) | $2.28M | $3.60M | (m) | $6.52M | $2.07M | (m) |
| 2015-03-31 | (m) | $2.14M | $2.90M | (m) | $6.39M | $2.40M | (m) |
| 2014-12-31 | (m) | $1.89M | $2.45M | (m) | $6.63M | $2.23M | (m) |
| 2014-09-30 | (m) | $2.16M | $2.28M | (m) | $6.36M | $2.24M | (m) |
| 2014-06-30 | (m) | $1.82M | $1.50M | (m) | $6.49M | $2.24M | (m) |
| 2014-03-31 | (m) | $2.41M | $772.43K | (m) | $6.47M | $2.55M | (m) |
| 2013-12-31 | (m) | $2.60M | $1.24M | (m) | $7.04M | $2.27M | (m) |
| 2013-09-30 | (m) | $2.36M | $1.08M | (m) | $7.99M | $1.43M | (m) |
| 2013-06-30 | (m) | $2.19M | $503.56K | (m) | $9.01M | $1.38M | (m) |
| 2013-03-31 | (m) | $4.25M | $504.95K | (m) | $9.20M | $2.14M | (m) |
| 2012-12-31 | (m) | $2.82M | $1.01M | (m) | $9.73M | $1.90M | (m) |
| 2012-09-30 | (m) | $3.74M | $1.48M | (m) | $10.42M | $2.31M | (m) |
| 2012-06-30 | (m) | $4.17M | $1.70M | (m) | $10.85M | $2.39M | (m) |
| 2012-03-31 | (m) | $4.03M | $1.39M | (m) | $11.09M | $2.41M | (m) |
| 2011-12-31 | (m) | $4.07M | $1.75M | (m) | $10.70M | $2.40M | (m) |
| 2011-09-30 | (m) | $4.49M | $2.95M | (m) | $10.40M | $2.16M | (m) |
| 2011-06-30 | (m) | $4.41M | $4.09M | (m) | $9.59M | $1.86M | (m) |
| 2011-03-31 | (m) | (m) | $3.95M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $5.16M | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $6.02M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $610.73K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |